Your session is about to expire
← Back to Search
Extracellular Matrix Scaffold
Meso Wound Matrix for Foot Ulcer
N/A
Waitlist Available
Research Sponsored by SerenaGroup, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial is designed to see if a Meso Wound Matrix can help heal Wagner grade 1 and 2 DFUs.
Eligible Conditions
- Diabetic Foot Ulcers
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Efficacy of Meso Wound Matrix
Secondary outcome measures
Adverse Events
Device Utilization
Health Economics
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Meso Wound Matrix and Standard of CareExperimental Treatment1 Intervention
This is a single arm study
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Meso Wound Matrix
2019
N/A
~30
Find a Location
Who is running the clinical trial?
SerenaGroup, Inc.Lead Sponsor
21 Previous Clinical Trials
1,782 Total Patients Enrolled
7 Trials studying Foot Ulcer
423 Patients Enrolled for Foot Ulcer
DSM Biomedical, Inc.UNKNOWN
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies available for individuals to join this research effort?
"Based on the data available via clinicaltrials.gov, this particular trial is not accepting applications as of now. Originally posted December 5th 2019 and last updated November 3rd 2022, there are however 128 other trials currently seeking participants for enrollment."
Answered by AI
Share this study with friends
Copy Link
Messenger